Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

55.60 -0.76 (-1.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Why Is Lantheus Stock Trading Lower On Wednesday?
CMS proposes a $140 drug packaging threshold and a $655 diagnostic radiopharmaceutical threshold for CY 2026, using inflation-adjusted PPI data. 
Via Benzinga
Why Lantheus (LNTH) Stock Is Down Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 7.7% in the morning session after the stock hit a new 52-week low amid persistent investor concerns over rising competition... 
Via StockStory
Topics ETFs Stocks World Trade
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued healthcare stock with strong profitability, financial health, and reasonable growth potential, making it a candidate for value investors. 
Via Chartmill
What Does the Market Think About Lantheus Holdings?
 
Via Benzinga
What Does the Market Think About Lantheus Holdings?
 
Via Benzinga
Earnings Scheduled For May 7, 2025
 
Via Benzinga
Spotting Winners: Lantheus (NASDAQ:LNTH) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q1
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Lantheus (NASDAQ:LNTH) and the best and... 
Via StockStory
Topics Artificial Intelligence
Shuttle Pharma Ramps Up Fight Against Glioblastoma With New Leadership, Promising Clinical Trial, and Bold Innovations
Via Stocktwits
Topics Cannabis
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) – An Undervalued Stock With Strong Fundamentals
Lantheus Holdings (NASDAQ:LNTH) presents an undervalued opportunity with strong profitability, financial health, and reasonable growth, making it a candidate for value investors. 
Via Chartmill
Lantheus Announces Presentations to be featured at the 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Present at the 2025 Truist Securities MedTech Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Holdings Inc (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
Lantheus Holdings (LNTH) is an undervalued stock with strong profitability, financial health, and growth potential, trading below industry averages. A solid pick for value investors. 
Via Chartmill
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next 
Via MarketBeat
Topics Earnings
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue... 
Via StockStory
Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
From DJS Law Group
Via Business Wire
Why Lantheus (LNTH) Shares Are Getting Obliterated Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 22.2% in the afternoon session after the company reported weak first quarter 2025 results which included a significant miss on... 
Via StockStory
Topics Artificial Intelligence
Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue... 
Via StockStory
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Sale of SPECT Business to SHINE Technologies
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Earnings: What To Look For From LNTH
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be announcing earnings results tomorrow before market open. Here’s what you need to know. 
Via StockStory
8 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
Company plans to file NDA in the third quarter of this year 
From Lantheus Holdings, Inc.
Via GlobeNewswire
In the world of growth stocks, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) shines as a value proposition.
LANTHEUS HOLDINGS INC could be undervalued. NASDAQ:LNTH is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. 
Via Chartmill
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - imaging, diagnostics stocks... 
Via StockStory
Topics Artificial Intelligence
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock which is not overvalued.
Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing... 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.